Abiopharma

GEVO, INC. (GEVO) Reports the reporting period Financial Results GEVO, INC. (GEVO) announced its financial results for the period ending the reporting period. Key Financial Highlights:

• Revenue: 42948
• Net Income: (21,697)
• EPS: Not disclosed
• Cash and equivalents: 78902
  • Jet Project Financing Plans●We launched a private capital raise to fund ATJ
  • 30, which would be the world’s largest ATJ project, after the previously announced withdrawal from the Department of Energy loan guarantee financing process.oThe project, which is expected to benefit from existing cash flows, captive ethanol feedstock production and carbon capture, has received initial non
  • binding indications of interest for project
    • targeting startup for the new facility at GND in 2028